pre-update Archives | 第 88 页，共 141 页 | Certara

网络研讨会点播

Agreeing to Submission Document Timelines & Sticking to Them: Fairy Tale or Reality?

In this webinar, Steve Sibley defined best practices for establishing submission timelines that won’t change,…

Certara2017 年 9 月 14 日

Publication

Medical Writing Competency Model—Section 2: Knowledge, Skills, Abilities, and Behaviors

Certara2017 年 8 月 30 日

Publication

Medical Writing Competency Model—Section 1: Functions, Tasks, and Activities

Certara2017 年 8 月 30 日

White Paper

药物资产评估：提高交易的 "成功概率”

Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…

Certara2017 年 8 月 24 日

Brochure

研究用药物差距分析

As the process of drug development has increased in cost and complexity, Certara has developed…

Certara2017 年 8 月 14 日

Press Coverage

临床药理学 – 药物开发的关键

Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…

Certara2017 年 8 月 14 日

Publication

Parent‐metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT‐888), a PARP Inhibitor, in Patients with BRCA 1/2–mutated Cancer or PARP‐sensitive Tumor Types

Certara2017 年 8 月 1 日

Publication

Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia Patients

Certara2017 年 7 月 15 日

Publication

Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics

Certara2017 年 7 月 1 日

Poster

Predicting Diclofenac Systemic and Synovial Fluid Concentrations After Dermal Application Using the Multi-phase Multi-layer MechDermA PBPK Model

Certara2017 年 6 月 6 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software